ATE81016T1 - Anwendung heterozyklischer dervate zur herstellung von arzneimitteln. - Google Patents

Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.

Info

Publication number
ATE81016T1
ATE81016T1 AT87311080T AT87311080T ATE81016T1 AT E81016 T1 ATE81016 T1 AT E81016T1 AT 87311080 T AT87311080 T AT 87311080T AT 87311080 T AT87311080 T AT 87311080T AT E81016 T1 ATE81016 T1 AT E81016T1
Authority
AT
Austria
Prior art keywords
dervatives
pharmaceuticals
heterocyclic
production
application
Prior art date
Application number
AT87311080T
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE81016T1 publication Critical patent/ATE81016T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87311080T 1986-12-17 1987-12-16 Anwendung heterozyklischer dervate zur herstellung von arzneimitteln. ATE81016T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630079A GB8630079D0 (en) 1986-12-17 1986-12-17 Medicaments
EP87311080A EP0275669B1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer Dervate zur Herstellung von Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE81016T1 true ATE81016T1 (de) 1992-10-15

Family

ID=10609120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311080T ATE81016T1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.

Country Status (5)

Country Link
EP (1) EP0275669B1 (de)
JP (1) JPS63277635A (de)
AT (1) ATE81016T1 (de)
DE (1) DE3782030T2 (de)
GB (1) GB8630079D0 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JP2007507425A (ja) * 2003-08-29 2007-03-29 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 胃腸管運動障害を処置するために有用な組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193592B (en) * 1984-01-25 1987-11-30 Glaxo Group Ltd Process for producing tetrahydro-carbazolone derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
EP0275669A1 (de) 1988-07-27
DE3782030T2 (de) 1993-02-18
EP0275669B1 (de) 1992-09-30
DE3782030D1 (de) 1992-11-05
GB8630079D0 (en) 1987-01-28
JPS63277635A (ja) 1988-11-15

Similar Documents

Publication Publication Date Title
ATE142107T1 (de) Verwendung von angiotensin-ii-antagonisten zur herstellung eines arzneimittels zur behandlung von hyperuricemie
NO176049C (no) Analogifremgangsmåte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-II-reseptorer
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
FR2617041B1 (fr) Orthese ou prothese pour la coordination des mouvements
ATE152623T1 (de) Verwendung von heterozyklischen derivaten zur herstellung von arzneimitteln
NO872589D0 (no) Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon.
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
NO942610D0 (no) Heterosykliske forbindelser og deres fremstilling og anvendelse
SE8503207D0 (sv) Pharmacologically active substituted benzamides
ATE119524T1 (de) Substituierte n-(imidazolyl)alkyl-alanin- derivate.
ATE95704T1 (de) Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.
ATE76411T1 (de) Cholecystokinin-antagonisten.
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
DE3782030D1 (de) Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
AT388731B (de) Neue derivate von benzimidazol, ihre herstellung und verwendung
DE3882545D1 (de) Verwendung von trifluormethansulfonamid gegen glaukom.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE88636T1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augenhypertension und glaukom.
DE68910444D1 (de) 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties